The bill also.... I want to touch on this briefly. There's been the suggestion that this is going to affect research and development, big pharma, that they would actually pull back funding from Canada. That's actually suggested by the department here, which is interesting. If the big pharma.... I don't care who it was, it would be a public relations issue, that they would actually punish a country for innovating and doing something different.
But they actually get a royalty. They will get payment out of that. Can you touch on that? They're not just going to watch their research and development and their thing be basically put on the Internet and thrown out there. There are provisions that protect. And second of all, they get a payment stream from the generics for that.